These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7742747)

  • 1. Detection of donor lymphocytes in the cerebrospinal fluid of a patient with metachromatic leukodystrophy following bone marrow transplantation.
    Yazaki M; Ohno T; Matsubayashi T; Yamada K; Osaka Y; Yamamori K; Ishikawa T; Wada Y; Sakuraba H
    Bone Marrow Transplant; 1995 Jan; 15(1):137-9. PubMed ID: 7742747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
    Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
    Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation.
    Malm G; Ringdén O; Winiarski J; Gröndahl E; Uyebrant P; Eriksson U; Håkansson H; Skjeldal O; Månsson JE
    Bone Marrow Transplant; 1996 Jun; 17(6):1003-8. PubMed ID: 8807106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-marrow transplantation for metachromatic leucodystrophy.
    Bayever E; Ladisch S; Philippart M; Brill N; Nuwer M; Sparkes RS; Feig SA
    Lancet; 1985 Aug; 2(8453):471-3. PubMed ID: 2863494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
    Koç ON; Day J; Nieder M; Gerson SL; Lazarus HM; Krivit W
    Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Hows J; Bradley BA; Gore S; Downie T; Howard M; Gluckman E
    Bone Marrow Transplant; 1993 Oct; 12(4):371-80. PubMed ID: 8275037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
    Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta MR; Vittone A; Terragna C; Pignatti PF; Tura S
    Haematologica; 1997; 82(2):156-60. PubMed ID: 9175318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis.
    Duggan P; Booth K; Chaudhry A; Stewart D; Ruether JD; Glück S; Morris D; Brown CB; Herbut B; Coppes M; Anderson R; Wolff J; Egeler M; Desai S; Turner AR; Larratt L; Gyonyor E; Russell JA;
    Bone Marrow Transplant; 2002 Nov; 30(10):681-6. PubMed ID: 12420207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO).
    Dini G; Cancedda R; Locatelli F; Bosi A; Bandini G; Alessandrino EP; Porta F; Uderzo C; Messina C; Fagioli F; Arcese W; Marenco P; Fanin R; Falda M; Soligo D; La Nasa G; Giardini C; Pession A; Scimè R; Di Bartolomeo P; Bruno B; Garbarino L; Lamparelli T; Giorgiani G; Lanino E; Manzitti C; Bacigalupo A;
    Haematologica; 2000 Nov; 85(11 Suppl):30-6. PubMed ID: 11268321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical related transplants and unrelated donor transplants with T cell addback.
    Veys PA; Meral A; Hassan A; Goulden N; Webb D; Davies G
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S42-4. PubMed ID: 9630324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.